Author

A. S. de Godoy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:protein structure· 1 Organism:virus· 1

Frequent Co-Authors

G. Oliva· 2 shared A. C. Puhl· 1 shared A. M. Nakamura· 1 shared A. Nakamura· 1 shared A. Nascimento· 1 shared A. T. Fabro· 1 shared A. Zeri· 1 shared F. Cunha· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

G. Oliva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintSep 30, 2021

Pyronaridine Protects Against SARS-CoV-2 in Mouse

A. C. Puhl, G. F. Gomes, S. Damasceno…·S. Ekins

Pyronaridine reduces SARS-CoV-2 viral load and lung pathology in mice, with in vitro inhibition of viral PLpro and host kinase CAMK1.

DOI 10.1101/2021.09.30.462449

mouseexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivDec 23, 2020

A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process

G. Noske, A. Nakamura, V. Gawriljuk…·A. S. de Godoy

This paper presents a crystal structure of an immature SARS-CoV-2 main protease, revealing conformational changes that hinder dimerization and activity, and identifies potential therapeutic targets.

DOI 10.1016/j.jmb.2021.167118

virusprotein structure

𝕏 PostBluesky